NEW YORK, May 20, 2014 /PRNewswire/ --
Today, Analysts Review released its analysts' notes regarding Air Products & Chemicals Inc. (NYSE: APD), Airgas Inc. (NYSE: ARG), Chemtura Corporation (NYSE: CHMT), Minerals Technologies Inc. (NYSE: MTX) and Balchem Corp. (NASDAQ: BCPC). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/2657-100free.
Air Products & Chemicals Inc. Analyst Notes
On May 15, 2014, Air Products & Chemicals Inc. reported that its board of directors has declared a quarterly dividend in the amount of $0.77 per share of common stock. The Company informed that the dividend is payable on August 11, 2014, to shareholders of record at the close of the business on July 1, 2014. The full analyst notes on Air Products are available to download free of charge at:
Airgas Inc. Analyst Notes
On May 15, 2014, Airgas Inc. (Airgas) announced that it has signed a long-term agreement for building an air separation unit (ASU) to supply tonnage oxygen and nitrogen via pipeline to Westlake Vinyls, Inc., at its expanded Calvert City, Kentucky manufacturing complex. "We're very excited about our new relationship with Westlake and look forward to serving their atmospheric gas needs in Calvert City with our new state-of-the-art production facility," said Airgas President and CEO, Michael L. Molinini. Airgas' new large-scale ASU is expected to be on-stream in the spring of 2016. The full analyst notes on Airgas are available to download free of charge at:
Chemtura Corporation Analyst Notes
On May 15, 2014, Chemtura Corp. (Chemtura) stock ended the day at $23.93 compared to the previous day's closing price of $24.73, representing a 3.23% decrease. The Company's stock went down 0.54% over the past five trading days, compared to the Dow Jones Industrial Average which declined 0.63% and to the Standard & Poor's 500, which also declined 0.25% during the same trading period. The full analyst notes on Chemtura are available to download free of charge at:
Minerals Technologies Inc. Analyst Notes
On May 13, 2014, Minerals Technologies, Inc. (MTI) announced that its Board of Directors has declared a quarterly dividend in the amount of $0.05 per share on the Company's common stock. MTI informed that the dividend is payable on June 11, 2014, to stockholders of record on May 28, 2014. The full analyst notes on MTI are available to download free of charge at:
Balchem Corp. Analyst Notes
On May 7, 2014, Balchem Corp. (Balchem) announced that it has completed the acquisition of Performance Chemicals & Ingredients Company (Sensor Effects), a supplier of customized food and beverage ingredient systems, headquartered in St. Louis, Missouri. The Company informed that it has acquired all of the outstanding capital stock of SensoryEffects for $567 million (before working capital and other adjustments). Dino A. Rossi, Chairman, President and CEO of Balchem stated, "We are pleased and excited to complete this acquisition. With similar cultures and a common vision, we look forward to working with an experienced partner like SensoryEffects, wherein we can accelerate the growth of our combined food and nutrition platforms with new and novel product offerings." The full analyst notes on Balchem are available to download free of charge at:
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts Review